Endoproteinase Lys-C

Jinan KangHe Pharmaceutical Technology Co., Ltd is the subsidiary company of AoHe pharmaceutical group that combine R&D, Production and Market sale as one of the innovative high-tech pharmaceutical enterprise, including subsidiary:
Jinan KangHe Pharmaceutical Technology Co., Ltd( R&D center-Jinan)
Shandong Lusheng Pharmaceutical Co., Ltd(Production Base-Dezhou）
AoHe pharmaceutical (Beijing) group( Marketing Center- Beijing)
Jinan KangHe Pharmaceutical Technology Co., Ltd was founded in 2011, located in Jinan High-tech Park 5150 high-level personnel new drug R&D base, and it’s focuses engagedin on the development of New Drug, and rRegistration and declaration. The main business cover R&D, production and sales of peptide, chemical and biological APIs and drug product as well as peptide for custom design, beauty peptide, peptide APIs, pharmaceutical intermediates processing and so on.
KangHe The company has a strong R & D of high-quality team, employed more than 200 research staffs, including graduate students graduated from key universities accounted for more than 65%, in addition, KangHe company is creating a post-doctoral workstations. In order to ensure leading technology, KangHe company also hired the first-class domestic medical experts as technical counselor.
KangHe The compainvested 320 million to build its production base according to the cGMP specification at national biology high-tech industrial park at Dezhou city in Shandong province. The Peptide APIs workshop conforms to cGMP standards according to America and Europe the DMF registration and edcertificationed. With the supply capacity of peptide APIs reach from grams to tens of kilograms.
KangHe The company has been adhering to the concept of "Health to the people, Harmony to the success". KangHe Focuses on R&D of new drug, following the world new drug development direction, forming a highly efficient system on the NDA and ANDA.